New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN From The Last 14 Days
Check below for free stories on DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
July 23, 2014
09:41 EDTNFLXActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL NFLX FB MSFT CELG TWTR TSLA VALE CNW
July 22, 2014
16:36 EDTNFLXOn The Fly: Closing Wrap
Subscribe for More Information
16:00 EDTNFLXOptions Update; July 22, 2014
Subscribe for More Information
12:29 EDTNFLXOn The Fly: Midday Wrap
Subscribe for More Information
11:53 EDTNFLXStocks with call strike movement; NFLX DAL
Netflix (NFLX) December 510 call option implied volatility decreased 9% to 34, Delta Air Lines (DAL) January 44 call option implied volatility increased 2% to 44 according to IVolatility.
11:10 EDTNFLXNetflix EU expansion modestly positive for Equinix, InterXion, says Wells Fargo
Subscribe for More Information
10:50 EDTNFLXNetflix retreats, analysts remain cautious as earnings miss estimate
Shares of Netflix (NFLX) are falling after several research firms reiterated their negative outlook on the stock following the company's second quarter results. WHAT'S NEW: Last night, Netflix reported Q2 earnings per share of $1.15, missing the consensus forecast of analysts by 1c, on revenue of $1.15B, which fell short of $1.33B consensus forecast. The company reported Q2 total streaming net additions of 1.69M, growing its total streaming members to just over 50M. The company guided to Q3 EPS of 89c and revenue of $1.22B, missing the consensus forecasts of $1.06 and $1.38B, respectively. The company said it expects Q3 net additions of 3.69M, to grow its membership to 53.74M. ANALYST OPINION: After Netflix reported slightly weaker than expected Q2 results and its Q3 guidance came in slightly below expectations, Jefferies analyst Brian Fitzgerald noted that the company indicated that it could lower its 2015 profit margin guidance. Netflix said its margin outlook will depend on the amount it spends on content, Fitzgerald added. The analyst believes that rising content costs pose a risk to the stock. He increased his price target on the shares to $350 from $300 but kept an Underperform rating on the stock. Also staying cautious on Netflix was research firm Bernstein. After Netflix suggested that its domestic margins may not rise as much as previously thought, the firm thinks the statement implies that either the company's subscriber growth could drop significantly or it may need to invest more in content. Additionally, Bernstein believes that the company's strong international guidance was based on the launch of new markets whose early results are difficult to predict. The outlook for the company's domestic subscription growth is still uncertain, but should become clearer in Q4 or the first quarter of 2015, added Bernstein, which kept a $260 price target and Underperform rating on the stock. Meanwhile, Citigroup continued to have an upbeat outlook on the company's fundamentals and its growth outlook, but kept a Neutral rating on the shares due to the stock's valuation. WHAT'S NOTABLE: A number of firms remained upbeat on Netflix, as Cantor said that the company has several positive catalysts, while JPMorgan called its results solid. Cantor kept a Buy rating on the stock, while JPMorgan reiterated its Overweight rating. PRICE ACTION: In early trading, Netflix fell $19.78, or 4.3% to $432.17.
10:48 EDTNFLXOptions with decreasing implied volatility
Options with decreasing implied volatility: IGT YHOO LYK ATHN CMG SWKS NFLX SHPG SNDK MTG
09:36 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:00 EDTNFLXNetflix price target raised to $500 from $425 at Cantor
Subscribe for More Information
07:57 EDTNFLXNetflix price target raised to $550 from $500 at JPMorgan
Subscribe for More Information
07:17 EDTNFLXNetflix outlook still uncertain, says Bernstein
Subscribe for More Information
06:49 EDTNFLXNetflix price target raised to $453 from $410 at Citigroup
Subscribe for More Information
06:31 EDTNFLXNetflix reported solid Q2 results, says Piper Jaffray
Subscribe for More Information
06:18 EDTNFLXNetflix price target raised to $350 from $300 at Jefferies
Subscribe for More Information
July 21, 2014
18:40 EDTNFLXOn The Fly: After Hours Movers
UP AFTER EARNINGS: Netflix (NFLX), up marginally after reporting Q2 results... Sanmina (SANM), up 13.2% after reporting third quarter results and fourth quarter guidance above analyst estimates... Chipotle (CMG), up 10.1%... Helix (HLX), up 5.2%... Canadian National (CNI), up 1.13%... CYS Investments (CYS), up 1.7%. ALSO HIGHER: Apache (APA), up 5% after Bloomberg says JANA discloses $1B position... Johnson & Johnson (JNJ), up 1% after announcing a $5B share repurchase program... TG Therapeutics (TGTX), up 4.3% after reporting second quarter results and preliminary clinical results from TG-1101 Phase I study... DOWN AFTER EARNINGS: Rambus (RMBS), down 3.6% after reporting second quarter results... Ultra Clean (UCTT), down 4% after reporting quarterly results. ALSO LOWER: Tallgrass Energy (TEP), down 5% after filing to sell 7M common units representing limited partners.
17:39 EDTNFLXNetflix says can achieve U.S-like margins in international business
Subscribe for More Information
17:32 EDTNFLXNetflix says very excited for 'ambitious' Marco Polo project
Subscribe for More Information
17:29 EDTNFLXNetflix sees producing original content for Europe expansion
Subscribe for More Information
17:20 EDTNFLXNetflix sees dip in Q4,Q1 free cash flow as company expands 'originals'
Subscribe for More Information
16:18 EDTNFLXNetflix says policy goal is for DOJ/FCC to block Comcast, TWC deal
Subscribe for More Information
16:07 EDTNFLXNetflix rallies 1% to $456.53 following Q2 results
Subscribe for More Information
16:07 EDTNFLXNetflix says international approaching contribution profitability
Subscribe for More Information
16:06 EDTNFLXNetflix to launch in Germany, France, others in September
Subscribe for More Information
16:05 EDTNFLXNetflix sees Q3 net additions 3.69M to 53.74M members
Subscribe for More Information
16:02 EDTNFLXNetflix reports Q2 total streaming net additions 1.69M
Netflix reports Q2 total streaming members 50.05M. The company reports international streaming net additions of 1.12M to 13.8M.
16:01 EDTNFLXNetflix sees Q3 EPS 89c, consensus $1.06
Sees Q3 revenue $1.22B, consensus $1.38B.
16:00 EDTNFLXNetflix reports Q2 EPS $1.15, consensus $1.16
Reports Q2 revenue $1.15B, consensus $1.33B.
15:30 EDTNFLXNotable companies reporting after market close
Subscribe for More Information
15:21 EDTNFLXNetflix July weekly 452 straddle priced for 8.1% move into Q2
Subscribe for More Information
14:38 EDTNFLXEarnings Preview: Analysts bullish on Netflix international expansion
Netflix (NFLX) is expected to report second quarter earnings after the market close on Monday, July 21 with a conference call scheduled for 5:00 pm ET. Netflix is an Internet subscription service that allows members to watch TV shows and movies through DVD and on-demand streaming. EXPECTATIONS: Analysts are looking for earnings per share of $1.16 on revenue of $1.33B. The consensus range is 93c-$1.42 for EPS, and $1.26B-$1.34B for revenue, according to First Call. LAST QUARTER: Netflix reported first quarter EPS of 86c against estimates of 83c, on revenue of $1.27B against estimates of $1.27B. It reported Q1 domestic net additions of 2.25M with total domestic members at Q1-end of 35.67M. Netflix also reported Q1 net international subscriber additions of 1.75M. The company gave Q2 guidance at that time of $1.12. It expects to add 520,000 domestic subscribers in Q2, 940,000 international subscribers in Q2, and total members to reach 49.81 at Q2-end. The company projects 60M-90M U.S. subscribers in the long-term. NEWS: Netflix raised its membership rate in early May by $1.00 to $8.99 for new subscribers while existing subscriber rates will be frozen for two years. A couple of weeks into the rate increase, Netflix said that it has seen "small customer reaction." Netflix said that it would significant expand internationally and specifically in Europe for 2H14. It plans to expand its content breath in upcoming quarters with "meaningful" originals in each market that could compete with "the top end of cable." Speaking on CNBC, CEO Reed Hastings added that he does not expect Netflix to introduce advertising now or in the near future. STREET RESEARCH: Several analyst firms, including Pacific Crest, RW Baird, JPMorgan and Topeka, are bullish on the company due to optimism for Netflix's international expansion that appears to be accelerating. Pacific Crest added that the company's international subscribers will likely surpass expectations. Citigroup, meanwhile, lowered 2014-2017 estimates to reflect the costs of the launch of service in the European market. Ahead of the Q2 earnings report, RW Baird expects solid Q2 results and Q3 forecast to reflect new market dilution. MKM Partners also believes that the company's Q2 results will likely beat expectations, adding that the stock could double or triple in the next four or five years. PRICE ACTION: Netflix shares have risen more than to 29% since the first day of trading following the company's Q1 report. In Monday mid-day trading ahead of Q2 report, Netflix shares are trading up 1.8%.
11:13 EDTNFLXNetflix technical commentary ahead of earnings
Subscribe for More Information
10:19 EDTMATHasbro tumbles after lower games performance weighs on sales
Subscribe for More Information
09:38 EDTNFLXActive equity options trading on open
Subscribe for More Information
07:21 EDTMRKGilead could be hurt by new HCV drugs, says Wells Fargo
Noting that data on a new Merck (MRK) HCV treatment is expected in November, Wells Fargo thinks Merck's HCV drug could be combined with Gilead's (GILD) Sovaldi to shorten the duration of treatment to four weeks. Other companies could take similar actions, and Gilead's per patient revenues would be significantly reduced if this occurs, the firm warned. However, it continues to have an upbeat outlook on Gilead heading into what it sees as a strong quarter and is still upbeat on the company's long-term HCV opportunity. It keeps an Outperform rating on Gilead.
06:43 EDTMRKGrowing market for hepatitis-C treatment prompts legal scramble, WSJ says
Subscribe for More Information
July 18, 2014
10:03 EDTMATOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:11 EDTMATMattel outlook still positive despite disappointing results, says MKM Partners
Subscribe for More Information
06:13 EDTMATMattel downgraded to Hold from Buy at Needham
Subscribe for More Information
05:57 EDTNFLXLevel 3 says Verizon 'deliberately' causing Netflix congestion
Subscribe for More Information
July 17, 2014
16:52 EDTMATOn The Fly: Closing Wrap
Subscribe for More Information
13:18 EDTMATOn The Fly: Midday Wrap
Subscribe for More Information
11:00 EDTMATHigh option volume stocks
High option volume stocks: OMC FXC TSEM JRJC MAT MTG PRAN SEAS BURL
10:55 EDTMATMattel topples after Q2 earnings miss estimates
Shares of global toy product manufacturer Mattel (MAT), are toppling over after the company's second quarter earnings results fell below analysts' consensus. WHAT'S NEW: Mattel's reported Q2 earnings per share of 8c, which was not comparable to a consensus of 18c since the company said its EPS number included a tax benefit of 11c per share and a negative impact of 7c per share of MEGA Brands acquisition and integration costs. Excluding both of these items, EPS was 3c per share. Mattel's Q2 revenue was $1.06B, which missed analysts' consensus estimates of $1.19B. For Q2, the company reported that its Girls and Boys Brands sales were down 13%, Fisher-Price Brands sales were down 17%, American Girl Bands revenue was up 6% and revenue from its Construction and Arts & Crafts Brands was $61.6M. WHAT'S NOTABLE: During its earnings conference conference call, Mattel said that it plans to increase advertising spending in the second half of the year to build momentum for key brands. It sees improving global trends in point-of-sale but says the company still has a lot of work to do to improve those trends. As Mattel looks to the third quarter, it sees continued challenges from current headwinds. With the MEGA brands deal now closed, the company aims to improve profitability of MEGA brands on a global basis and believes the acquisition will be accretive to earnings in fiscal year 2015. It expects lower international sales and is investing heavily in markets in Russia and China. Mattel is looking to maintain gross margins in the low to mid-50% range in near term. It noted that it aims to achieve a modest increase in SG&A due to severance and ongoing growth investments, excluding the MEGA Brands acquisition. Inventory fair value adjustment related to existing MEGA Brands-owned inventory should wind down in Q3, the company said. Amortization is expected to decrease to $17M in 2015 and $9M in 2016. PRICE ACTION: Shares of Mattel are down $2.31, or 5.92%, to $36.72 in morning trading. OTHERS TO WATCH: Mattel peer Hasbro (HAS), which reports quarterly earnings on July 21, is relatively flat at $52.59. JAKKS Pacific (JAKK) is up almost 1.5% to $8.20 and and LeapFrog (LF) is up 3.02% to $7.66.
09:49 EDTMATMattel says gearing-up for holiday season sales in 2H14
Says investing heavily in Russia and China markets.
09:31 EDTNFLXNetflix, Disney announce multi-year pay TV window agreement in Canada
Subscribe for More Information
09:31 EDTMATMattel says 'Frozen' brand continuing to grow
Subscribe for More Information
09:15 EDTMATOn The Fly: Pre-market Movers
HIGHER: Dresser-Rand (DRC), up 15.5% after Manager Magazin says Siemens (SIEGY) preparing bid for the company. Other oil equipment companies with a market cap similar to Dresser-Rand's include Dril-Quip (DRQ) and Oil States (OIS)... Microsoft (MSFT), up 3.4% after announcing restructuring, including plans to cut up to 18K jobs. UP AFTER EARNINGS: Morgan Stanley (MS) up 1.5%... Sherwin-Williams (SHW), up 3%. DOWN AFTER EARNINGS: Mattel (MAT), down 7.3%... Sandisk (SNDK), down 7%... Yum! Brands (YUM), down 2.5%. LOWER: Orbitz (OWW), down 3% after results, 34M share spot secondary offering of stock priced at $8.25... Benefitfocus (BNFT), down 1% after 2.5M share Secondary priced at $38.50.
09:08 EDTMATMattel to increase advertising spending in 2H14
Subscribe for More Information
08:17 EDTMATMattel aims to maintain gross margins in low to mid-50% range in near term
Says its 2014 SG&A goal, excluding MEGA Brands, remains to achieve modest increase in Mattel SG&A, including severance and ongoing growth investments. Says inventory fair value adjustment, required by purchase accounting for opening balance sheet, related to existing MEGA Brands-owned inventory should wind down in Q3. Says amortization expected to decrease to $17M in 2015 and $9M in 2016. Comments taken from slides of the company's Q2 earnings conference call presentation.
07:31 EDTNFLXNetflix Q2 results likely to beat expectations, says MKM Partners
Subscribe for More Information
07:20 EDTNFLXNetflix July weekly volatility elevated into Q2 and outlook
Netflix July weekly call option implied volatility is at 77, August is at 49, September is at 40; compared to its 26-week average of 44 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on July 21.
07:05 EDTALKSAlkermes announces initiation of Phase 1 study of ALKS 8700 for treatment of MS
Subscribe for More Information
06:18 EDTMATMattel reports Q2 Girls and Boys Brands sales down 13% to $389M
Subscribe for More Information
06:18 EDTMATMattel reports Q2 EPS 8c, not comparable to consensus 18c
Q2 EPS of 8c includes tax benefit of 11c per share and negative impact of 7c per share of MEGA Brands acquisition and integration costs. Reports Q2 revenue $1.06B, consensus $1.19B
July 16, 2014
17:23 EDTTSNTyson Foods commences tender offer for Hillshire Brands for $63 per share cash
Tyson Foods (TSN) announced that it has commenced a cash tender offer for all outstanding shares of common stock of Hillshire Brands (HSH) at a price of $63.00 per share. The tender offer is being made pursuant to the previously announced merger agreement dated July 1, among the two companies and HMB Holdings, a wholly owned subsidiary of Tyson Foods. The tender offer period will expire at 12:00 midnight at the end of the day on August 12, unless the offer is extended. Tyson Foods has filed a tender offer statement on Schedule TO with the United States SEC. HMB Holdings is the acquirer in the tender offer. The Offer to Purchase contained within the Schedule TO sets out the terms and conditions of the tender offer. Hillshire Brands has also filed a Solicitation/Recommendation Statement with the SEC, which includes the recommendation of the Hillshire board of directors that Hillshire Brands stockholders tender their shares in the tender offer. Following successful completion of the tender offer, any shares not acquired in the tender offer will be acquired in a second-step merger at the same $63 per share cash price.
15:17 EDTNFLXNetflix quietly ends Saturday DVD deliveries to lower costs, LAT says
Subscribe for More Information
14:55 EDTMATMattel July 39 straddle priced for 5.1% move into Q2
Subscribe for More Information
14:03 EDTNFLXNetflix submits FCC comments on proposed Net Neutrality rules
Subscribe for More Information
11:50 EDTMATMattel technical comments before earnings
Subscribe for More Information
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
06:26 EDTMRKBristol-Myers lung cancer trials being underestimated, says Citigroup
After building a statistical model of Bristol-Myers' two critical registration trials for Opdivo in lung cancer, Citigroup believes the market is "materially" underestimating both Phase III trials. Citi says potential Opdivo FDA approval in 2015 in lung cancer would give Bristol-Myers an up to two year lead time versus Merck (MRK) and Roche (RHHBY). The firm estimates 2023 Opdivo revenue at $7B and reiterates a Buy rating on Bristol with a $60 price target.
July 15, 2014
11:13 EDTMRKPerrigo retreats after analyst sees limited potential buyers
Subscribe for More Information
08:11 EDTMRKMerck looks to revive livestock drug Zilmax, WSJ says
Merck has been preparing to conduct a large-scale study this summer to evaluate the safety of its Zilmax feed additive, which the company pulled from the U.S. market last year over concerns in the beef industry that the drug made it difficult for some animals to walk, reported The Wall Street Journal. Reference Link
08:03 EDTNFLXPublic speak out on FCC 'net-neutrality' plan, WSJ says
The Federal Communications Commission's has received more than 677K comments so far from the public on its proposed 'net-neutrality' rules for how broadband providers can treat content traveling over their networks and a random sampling of the input suggests that the agency will have work to do to sell the plan, according to The Wall Street Journal. Companies that provide broadband Internet service include Comcast (CMCSA), AT&T (T), Verizon (VZ) Time Warner Cable (TWC), and Cablevision (CVC). Netflix (NFLX) sends a great deal of content over the Internet and strongly supports net neutrality. Reference Link
07:35 EDTMRKPerrigo potential buyers list could be limited, says Jefferies
After Globes reported that Perrigo retained an investment bank to assist with a potential merger, Jefferies says the list of potential buyers could be limited since the store brand business is fundamentally a high volume, lower margin model. The firm notes U.S. companies that currently do not have large over-the-counter divisions include Bristol-Myers (BMY), Eli Lilly (LLY) and Merck (MRK). Jefferies views the merger speculation surrounding Perrigo as not surprising given the company's strong long-term fundamentals and attractive Irish domicile. It has a Buy rating on the stock with a $160 price target.
July 14, 2014
16:00 EDTNFLXOptions Update; July 14, 2014
Subscribe for More Information
July 12, 2014
12:37 EDTADNCAudience completes acquisition of Sensor Platforms
Audience announced that it has completed its acquisition of Sensor Platforms. Sensor Platforms develops software and algorithms that interpret sensor data to enable broad context awareness on smartphones, wearables and other smart devices. Audience believes the combination of its Advanced Voice and Multisensory Processing with Sensor Platforms' technology places the combined company in a unique position to deliver compelling solutions based on the fusion of voice and motion. The company noted, "Joining these technologies will help transform the way consumers engage with devices, by enabling seamless natural user experiences, always-on sensor fusion, and context-aware services." With the close of the acquisition, the Sensor Platforms' team is now part of Audience. The acquisition was completed on July 11 for consideration of $41M of cash.
July 11, 2014
08:59 EDTNFLXNetflix price target to $500 on international opportunity at Raymond James
Subscribe for More Information
07:38 EDTALKSHouse Energy & Commerce Committee to hold a hearing
Subscribe for More Information
07:25 EDTMATMattel July volatility elevated into Q2 and outlook
Mattel July call option implied volatility is at 40, August is at 23, October is at 20; compared to its 26-week average of 22 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on July 17.
06:10 EDTNFLXJPMorgan expects solid Q2 results in Internet space
Subscribe for More Information
July 10, 2014
16:12 EDTMRKMedivation names Dawn Svoronos as Chief Commercial Officer
Medivation (MDVN) announced Dawn Svoronos has been appointed as its chief commercial officer, reporting to David Hung, M.D., founder, CEO and president of Medivation. Svoronos currently is a member of Medivation's Board of Directors and is a former president of Europe and Canada for Merck & Co. (MRK), where she oversaw commercial operations in approximately 30 EU and EU accession countries. Svoronos will lead Medivation's commercial organization on an interim basis and will participate in the company's search for a permanent chief commercial officer. Cheryl Cohen, Medivation's former chief commercial officer, has left the company to pursue other opportunities.
16:00 EDTNFLXOptions Update; July 10, 2014
Subscribe for More Information
08:03 EDTMCKAccretive Health names Emad Rizk as CEO and president
Accretive Health (ACHI) announced that its Board of Directors has appointed Emad Rizk, M.D., president of McKesson Health Solutions (MCK), as CEO, President, and a member of the Board of Directors, effective July 21.
July 9, 2014
13:44 EDTNFLXNetflix wins video on demand rights to 'Zoo' series, Variety reports
Subscribe for More Information
09:35 EDTNFLXActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AA FB AMZN TSLA TWTR MU NFLX GG CELG
07:04 EDTALKSAlkermes announces notice of allowance for four pipeline candidates
Subscribe for More Information
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use